Literature DB >> 1349619

Internalization of a major group human rhinovirus does not require cytoplasmic or transmembrane domains of ICAM-1.

D E Staunton1, A Gaur, P Y Chan, T A Springer.   

Abstract

Intercellular adhesion molecule-1 (CD54), a cell adhesion molecule and the receptor for the major group of rhinoviruses, is a class 1 membrane protein with five Ig-like domains in its extracellular region, a transmembrane domain, and a short cytoplasmic domain. The amino-terminal domains (D1 and D2) are sufficient for virus binding and the first is most important (1). We have investigated whether other extracellular domains, transmembrane or cytoplasmic domains are required for virus entry as determined by postinfection virion protein biosynthesis. We demonstrate that cytoplasmic, transmembrane, and Ig-like domains 3, 4, and 5 are not essential for rhinovirus entry into transfected COS cells. The efficiency of rhinovirus infection directly correlates with the efficiency of rhinovirus binding and a form of intercellular adhesion molecule-1 that is glycophosphatidyl-inositol anchored, and thus does not extend into the inner leaflet of the membrane bilayer or the cytoplasm efficiently supports virus entry.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349619

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Engineering of single Ig superfamily domain of intercellular adhesion molecule 1 (ICAM-1) for native fold and function.

Authors:  Róisín M Owens; Xiaoling Gu; Miran Shin; Timothy A Springer; Moonsoo M Jin
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

2.  Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms.

Authors:  D Schober; P Kronenberger; E Prchla; D Blaas; R Fuchs
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  Analysis of foot-and-mouth disease virus internalization events in cultured cells.

Authors:  Vivian O'Donnell; Michael LaRocco; Hernando Duque; Barry Baxt
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  CTLA4 mediates antigen-specific apoptosis of human T cells.

Authors:  J G Gribben; G J Freeman; V A Boussiotis; P Rennert; C L Jellis; E Greenfield; M Barber; V A Restivo; X Ke; G S Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

5.  Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released.

Authors:  J M Casasnovas; T A Springer
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

6.  Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication.

Authors:  M E Morrison; Y J He; M W Wien; J M Hogle; V R Racaniello
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

7.  Glycosyl-phosphatidylinositol-anchored and transmembrane forms of CD46 display similar measles virus receptor properties: virus binding, fusion, and replication; down-regulation by hemagglutinin; and virus uptake and endocytosis for antigen presentation by major histocompatibility complex class II molecules.

Authors:  G Varior-Krishnan; M C Trescol-Biémont; D Naniche; C Rabourdin-Combe; D Gerlier
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1.

Authors:  J Miller; R Knorr; M Ferrone; R Houdei; C P Carron; M L Dustin
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

9.  The clathrin endocytic pathway in viral infection.

Authors:  L DeTulleo; T Kirchhausen
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

10.  Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection.

Authors:  X Wang; J M Bergelson
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.